Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
Observational Model: Cohort, Time Perspective: Prospective
Time in weeks to fifty percent decrease in sural nerve action potential amplitude
Eugene A Lesser, D.O.
United States: Food and Drug Administration
|Santa Clara Valley Health and Hospital System||Santa Clara, California 95128|